CardiaTec Biosciences

CardiaTec Biosciences is a Cambridge-based biotech applying artificial intelligence to large-scale multi-omic data to identify novel drug targets for cardiovascular diseases.

Its platform integrates data across genomic, epigenomic, transcriptomic, proteomic and metabolomic layers to map disease mechanisms and uncover previously unrecognised therapeutic targets.

It sources proprietary human cardiac tissue data from a network of over 65 hospitals across the UK and US.